Covering the operations of the oil and gas industry
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
Sections
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
LNG
Energy Transition
Industry Statistics
Members Only
Special
Webcasts
White Papers
Podcast
Magazine
Surveys
Research
Events
Submit an Article
Iran war
Contact
About Us
Subscribe
Newsletters
Advertise
Contact Us
Privacy Policy
Terms & Conditions
Affiliated Brands
OFFSHORE
ENERGYTECH
MICROGRID KNOWLEDGE
OGJ RESEARCH
Follow us on
http://www.facebook.com/ogjonline
https://www.linkedin.com/company/oil-&-gas-journal
http://twitter.com/ogjonline
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
4
Next >
Trump's pharmaceutical tariffs could affect some drugmakers more than others
July 29, 2025
Tags
US: News
AbbVie Inc
Elanco Animal Health Inc
From
CNBC.com News
FDA taps biotech industry veteran as RFK Jr.'s top drug regulator
July 21, 2025
Tags
Sarepta Therapeutics Inc
Social issues
Business News
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
AstraZeneca PLC
Biogen Inc
Breaking News: Investing
From
CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
February 12, 2025
Tags
Pharmaceuticals
Companies
Health & Science
From
CNBC.com News
5 things to know before the stock market opens Monday
February 10, 2025
Tags
CVS Health Corp
Business
Economy
From
CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags
Science
Eisai Co Ltd
Biotech and Pharmaceuticals
From
CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024
Tags
Health care industry
Breaking news
Business News
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
Abbvie Inc
Amgen Inc
Caterpillar Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Investing
Apple Inc
Biogen Inc
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
September 25, 2024
Tags
Netflix Inc
Stock markets
GE Vernova Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
September 09, 2024
Tags
Business
Investing
Biogen Inc
From
CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
Eisai Co Ltd
Science
Biotech and Pharmaceuticals
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Breaking News: Earnings
US: News
Biotechnology
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Eisai Co Ltd
Science
Biotech and Pharmaceuticals
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Breaking News: Business
Biogen Inc
Companies
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Health care industry
Business News
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Stock markets
Investment strategy
Business News
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
Mad Money
stocks
Investment Strategy
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
Biotechnology
US: News
Biogen Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Bristol/Myers Squibb Co
General Motors Co
Humana Inc
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Eisai Co Ltd
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Biogen Inc
Health care industry
Health & Science
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
Health care industry
Breaking news
Business News
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
Tesla Inc
Anheuser/Busch Inbev SA
Technology
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Biotech and Pharmaceuticals
Eisai Co Ltd
Science
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Biotechnology
Eli Lilly and Co
US: News
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
Lyft Inc
MGM Resorts International
Walt Disney Co
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Business
Pharmaceuticals
Health & Science
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
Health care industry
Depression
Breaking news
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
Enphase Energy Inc
Earnings
Procter & Gamble Co
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.